Is Psilocybin Legal in New Zealand?

⚠️ Not Legal Advice

This page is for educational purposes only and does not constitute legal advice. Drug laws change frequently. Always verify the current status directly with the New Zealand Ministry of Health (https://www.health.govt.nz) or New Zealand Police drug law guidance, or consult a qualified New Zealand lawyer before making any decisions. Penalty ranges below are maximums and actual sentencing depends heavily on quantity, intent, and individual circumstances.

Last reviewed: July 2026. This entry is drawn from Psilobase's broader Legal Status by Country guide. Because psilocybin law is an actively moving target worldwide, treat any date-stamped legal claim — including this one — as needing re-verification if you are reading it more than a few months after the review date above.

Quick Answer

Psilocybin is a Class A controlled drug in New Zealand under the Misuse of Drugs Act 1975 — the same top-tier classification given to heroin and methamphetamine. Possession, cultivation, and supply are all criminal offences. Penalties for small personal-use amounts tend to be at the lower end of what the law allows in practice, but prosecution is still possible, and supply-level quantities are treated much more seriously. There is no decriminalisation, medical access scheme, or truffle-style loophole for psilocybin in New Zealand as of 2026.

Current Legal Status in New Zealand

Under the Misuse of Drugs Act 1975, psilocybin and psilocin are Class A substances. Possession of a small personal amount can, in practice, attract penalties at the lower end of the statutory range (guidance in this guide's comparison table cites up to roughly 6 months' imprisonment or a fine for small quantities), but larger amounts move toward the statutory maximum of up to 2 years for possession and considerably more for cultivation or supply. Supply and dealing offences carry much harsher penalties, up to 14 years' imprisonment under the Act, reflecting Class A's top-tier status. New Zealand does not have any local decriminalisation ordinances (unlike some US cities), a supervised-access framework (unlike Oregon or Colorado), or a botanical loophole (unlike the Netherlands' truffles). Research access requires a ministerial exemption and is rare in practice, though clinical interest in psychedelic-assisted therapy has been growing internationally and New Zealand researchers have discussed potential trial proposals.

History: How the Law Got Here

The Misuse of Drugs Act 1975 has governed New Zealand drug law for five decades and places psilocybin/psilocin in Class A alongside other high-restriction substances. Broader New Zealand drug policy debate has focused mainly on cannabis: a 2020 national referendum on legalising recreational cannabis narrowly failed, with 50.7% voting against legalisation. That result is widely seen as having dampened political appetite for broader drug law liberalisation — including for psilocybin — in the years since, even as New Zealand has separately pursued harm-reduction measures such as drug-checking services at festivals and events. The Drug Foundation of New Zealand, a prominent harm-reduction advocacy group, has continued to push for reform, but no legislative change to psilocybin's Class A status has occurred as of 2026.

How to Verify This Yourself

Laws referenced on this page were last reviewed in July 2026. Before making any decision based on legal status, check directly with the New Zealand Ministry of Health: https://www.health.govt.nz, or New Zealand Police's official drug law resources. For broader cross-country comparison and additional official sources, see the full Legal Status by Country guide.